Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 3, 2026
November 2, 2026
4f8b1a40-446b-496a-884e-cb6031f8368b
Related Documents
Guidance for Industry: Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentNovember 2, 2026Center for Biologics Evaluation and Research
Use of Serological Tests to Reduce the Risk of Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II (HTLV-I/II): Guidance for Industry
Guidance DocumentFebruary 5, 2020Center for Biologics Evaluation and Research
Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis: Guidance for Industry
Guidance DocumentMay 9, 2019Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.